Interchange Capital Partners’s Twist Bioscience TWST Stock Holding History

Interchange Capital Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Buy	+2,588	New	+$168K	0.05%	332

Other funds holding TWST

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Abacus Wealth Partners Santa Monica, California $952M AUM 22.68% 1-Year Est. Return

Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return

Interchange Capital Partners's TWST Position: Q2 2026 in Review

Interchange Capital Partners opened a new position in Twist Bioscience (TWST) in Q2 2026: 2,588 shares worth $266K. The stake represents 0.05% of the portfolio and ranks #332 among its holdings.

27 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Interchange Capital Partners held 2,588 shares of Twist Bioscience worth $266K as of Q2 2026.
Twist Bioscience was a new Interchange Capital Partners position in Q2 2026.
Twist Bioscience made up 0.05% of Interchange Capital Partners's portfolio in Q2 2026, its #332 holding.
27 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.